| 摘要 |
The invention relates to a method for the treatment of a disease suscepti ble to anti-EGFR treatment, comprising the step of administering, to a human being in nee thereof, a combination of an anti-EGFR agent and an anti-neutr ophil-chemoattracta agent, wherein said anti-neutrophil-chemoattractant agen t is administered in a dosag regimen that is sufficient to reduce one or mor e undesired dermatological side-effects the anti-EGFR agent. In one embodime nt, the anti-EGFR agent is an anti-EGF antibody and the anti-neutrophil-chem oattractant agent is an anti-IL-8 antibody. |
